Healthcare Services Group, Inc. (HCSG) AI Stock Analysis

NASDAQ: HCSGAI research summary: business, growth, valuation, analysts, bull and bear case.

HCSG AI stock analysis summary

AI Research

Healthcare Services Group, Inc. (HCSG) provides housekeeping, laundry, and dietary services to healthcare facilities across the United States. In FY2025, revenue grew 7.1% to $1.84B with net income of $59.1M, supported by a net cash balance of $183.1M as of June 30, 2026. The stock trades at a trailing P/E of 12.4x and gained 28.7% over the past year.

Market cap
$1.45B
Revenue (TTM)
$1.86B
P/E
12.4x
fwd 17.4x
1Y return
28.7%
S&P 500 16.8%
Avg. target
$26.67
26.2% vs last close

Bull case

  • Free cash flow expanded to $139.2M in FY2025, up from $24.5M in FY2024.
  • The balance sheet maintains $183.1M in net cash with total debt of only $17.7M as of June 30, 2026.
  • The trailing P/E of 12.4x trades at a substantial discount to the median of its US-listed Healthcare peers of 24.6x.

Bear case

  • Five-year revenue CAGR from FY2020 to FY2025 was limited to 0.9%.
  • Operating margin of 2.6% in FY2025 remains modest relative to the peer median TTM operating margin of 14.0%.
  • The stock produced a 5-year return of -0.6%, substantially trailing the S&P 500 return of 83.0%.

What Healthcare Services does

Healthcare Services Group, Inc. delivers management, administrative, and operational services to healthcare facilities across the United States, including nursing homes, retirement complexes, rehabilitation centers, and hospitals. The company operates through two core segments: Housekeeping and Dietary. In the Housekeeping segment, it handles cleaning, disinfection, and sanitization of resident rooms and communal areas, along with laundry processing for linens and uniforms. In the Dietary segment, it manages food purchasing, meal preparation, nutritional planning guided by professional dietitians, on-site management, and clinical consulting. Founded in 1976 and based in Bensalem, Pennsylvania, the company served approximately 3,000 facilities nationwide as of December 31, 2021.

Growth and profitability

Between FY2021 and FY2025, revenue increased from $1.64B to $1.84B, yielding a 5-year revenue CAGR of 0.9%. Top-line performance fluctuated over that period, with revenue rising 2.9% in FY2022, declining 1.1% in FY2023, expanding 2.7% in FY2024, and climbing 7.1% in FY2025. Gross margin was 13.0% and operating margin was 2.6% in FY2025, while net income rose to $59.1M with EPS of $0.82. In the trailing twelve months ended June 30, 2026, revenue stood at $1.86B with a profit margin of 6.6%. In the latest quarter, year-over-year revenue grew 2.7% and quarterly earnings increased 60.9%.

HCSG income statement →

Balance sheet and cash flow

As of June 30, 2026, Healthcare Services Group held $200.9M in cash and short-term investments alongside $17.7M in total debt, creating a net cash position of $183.1M. The company reported a current ratio of 3.02 and a debt-to-equity ratio of 0.03 against $518.8M in shareholders' equity. In FY2025, operating cash flow was $145.0M and free cash flow reached $139.2M. Capital expenditures totaled $5.8M, while $61.6M was used for share buybacks, contributing to a 5-year share count change of -5.2%.

HCSG balance sheet →

Valuation and performance

HCSG carries a market capitalization of $1.45B and an enterprise value of $1.31B. Its trailing P/E of 12.4x sits below the median of its US-listed Healthcare peers of 24.6x, while its forward P/E of 17.4x compares with the peer median of 17.3x. The stock trades at an EV/EBITDA of 7.8x versus the peer median of 12.0x, and a price-to-sales ratio of 0.8x against the peer median of 4.1x. Over the past year, the stock returned 28.7%, exceeding the S&P 500 (SPY) return of 16.8%, although its 5-year return of -0.6% lagged the index return of 83.0%.

HCSG key metrics →

What analysts expect

Wall Street coverage includes 4 Strong Buy ratings and 3 Hold ratings, with no Sell or Strong Sell recommendations. The mean price target is $26.67, indicating 26.2% upside from the last close of $21.13. For the fiscal year ending December 31, 2026, consensus estimates project revenue of $1.92B and EPS of $1.20, representing 47.7% EPS growth. For the subsequent fiscal year, 7 analysts anticipate revenue of $2.06B and EPS of $1.22. The company recorded 4 EPS beats over the last 4 quarters, with its next earnings date set for October 21, 2026.

HCSG forecast and price target →

Key risks and what to watch

  • Operating margin declined from 3.9% in FY2021 to 2.6% in FY2025, which narrows the buffer against operating cost increases.
  • Free cash flow has exhibited volatility, dropping to -$13.4M in FY2022 before recovering in later fiscal years.
  • Annual revenue growth was negative in FY2021 (-6.7%) and FY2023 (-1.1%), demonstrating uneven customer demand or facility retention.

AI-generated research summary. Written with AI from Quotelinks data as of October 16, 2026 and checked so every figure matches that data. For information only, not investment advice. Disclaimer

About this HCSG AI stock analysis

This page is an AI-written research summary of Healthcare Services Group, Inc. (HCSG). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: HCSG income statement, HCSG balance sheet, HCSG key metrics, HCSG analyst forecast, HCSG chart. See the HCSG stock overview for the latest quote and news.

HCSG AI stock analysis FAQ

What do analysts expect for HCSG's earnings growth?

For the fiscal year ending December 31, 2026, analysts estimate EPS of $1.20, which represents 47.7% growth over the prior year. Next fiscal year EPS is projected at $1.22 on $2.06B in revenue.

How does HCSG's valuation compare to its peer group?

HCSG trades at an EV/EBITDA of 7.8x and a trailing P/E of 12.4x. Both figures are lower than the median of its US-listed Healthcare peers of 12.0x and 24.6x, respectively.

What is the financial position of Healthcare Services Group?

As of June 30, 2026, the company held $200.9M in cash and short-term investments against $17.7M in total debt, giving it $183.1M in net cash and a current ratio of 3.02.

When is Healthcare Services Group's next earnings report?

The next earnings date is scheduled for October 21, 2026. The company has beaten EPS expectations in each of its last 4 quarters.

More Healthcare AI stock analysis